Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New nasal spray could speed up overdose reversal

NCT ID NCT05377255

First seen Apr 24, 2026 · Last updated May 22, 2026 · Updated 3 times

Summary

This early-stage study tested a new naloxone nasal spray device in 24 healthy adults to see how well it delivers the drug and if it's safe. Naloxone is a life-saving medicine that reverses opioid overdoses. The study compared the new device to an existing one, measuring drug levels in the blood and checking for side effects like nasal irritation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID OVERDOSE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Syneos Health Clinical Research Services

    Miami, Florida, 33136, United States

Conditions

Explore the condition pages connected to this study.